Kerri Fitzgerald

DocwireNews

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) improved survival in patients with <a href="https://proddocwire.wpengine.com/abstracts/ultrasound-in-the-re-staging-of-cervical-metastases-after-chemoradiotherapy-for-head-and-neck-cancer/">head and neck</a> squamous cell carcinoma (HNSCC) with PIK3CA mutations or amplification, according to a study published in the Journal of Experimental Medicine.Researchers evaluated 266 patients with HNSCC from a single center.Among those with PIK3CA mutations or amplification, regular NSAID use (defined as &ge;6 months) was associated with prolonged disease-specific survival (DSS; hazard ratio [HR] = 0.23; 95% CI, 0.09-0.62; P = 0.0032) and overall survival (OS; HR=0.31; 95% CI, 0.14-0.69; P = 0.0043) compared with patients who did not regularly use NSAIDs.<blockquote class="twitter-tweet" data-width="500" data-dnt="true">
Use of non-steroidal anti-inflammatory drugs, or NSAIDs, significantly improves survival for a third or more patients with head and neck cancer, shows a new study published in <a href="https://twitter.com/JExpMed?ref_src=twsrc%5Etfw">@JExpMed</a> (<a href="https://t.co/b9uwZn01oV">https://t.co/b9uwZn01oV</a>). Read news coverage in The <a href="https://twitter.com/Independent?ref_src=twsrc%5Etfw">@Independent</a>: <a href="https://t.co/5Q892irl1q">https://t.co/5Q892irl1q</a>
&mdash; Rockefeller U. Press (@RockUPress) <a href="https://twitter.com/RockUPress/status/1089987740790345728?ref_src=twsrc%5Etfw">January 28, 2019</a>
</blockquote><script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script>Predicted five-year DSS was 72% for NSAID users and 25% for non-users among patients with PIK3CA-altered HNSCC (HR=0.24; P = 0.0032). Predicted five-year OS was 78% and 45%, respectively.Aspirin was a component of the NSAID regimen in 93% of regular users, and 73% used aspirin exclusively. Most regular users (86%) began NSAID therapy after being diagnosed with HNSCC.&ldquo;These findings uncover a biologically plausible rationale to implement NSAID therapy in PIK3CA-altered <a href="https://proddocwire.wpengine.com/abstracts/effect-pregabalin-radiotherapy-neuropathic/">HNSCC</a>,&rdquo; the researchers concluded.&nbsp;&nbsp;Source: <a href="http://jem.rupress.org/content/early/2019/01/25/jem.20181936">Journal of Experimental Medicine</a>

Jordana Jampel

FDA Approves Novel Blood Test for Alzheimer’s Detection

Dementia

Andrew Moreno

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Katie Kosko

EMBER-3: Imlunestrant Plus Abemaciclib Improves PFS in ER+ Breast Cancer

HR Breast Cancer

Latest News

Study Find NSAIDs Improve Survival in Head and Neck Cancer

Head and Neck Cancer

Regular use of aspirin or other nonsteroidal anti-inflammatory drugs (NSAIDs) improved survival in patients with head and neck squamous cell carcinoma (HNSCC) with PIK3CA ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe